These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36544770)

  • 1. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.
    Sun M; Ji X; Xie M; Chen X; Zhang B; Luo X; Feng Y; Liu D; Wang Y; Li Y; Liu B; Xia L; Huang W
    Front Immunol; 2022; 13():999084. PubMed ID: 36544770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
    Luo W; Xiang W; Gan L; Che J; Li J; Wang Y; Han L; Gu R; Ye L; Wang R; Zhang X; Xu Y; Dai W; Mo S; Li Q; Cai G
    J Transl Med; 2022 May; 20(1):235. PubMed ID: 35590418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
    Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
    J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a novel necroptosis-related molecular signature to evaluate prognosis and immune features in breast cancer.
    Zhang F; Qi C; Yao Z; Xu H; Zhou G; Li C; Xia H
    Apoptosis; 2023 Dec; 28(11-12):1628-1645. PubMed ID: 37787960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic Model Associated with Necroptosis in Colorectal Cancer based on Transcriptomic Analysis and Experimental Validation.
    Huang Y; Li L; Kang Z; Luo H; Lin X; Zhao S; Zhang Q; Li Q; Liu H; Li M
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):98. PubMed ID: 38538261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Analysis of Necroptosis-Related Genes for Prognosis, Immune Microenvironment Infiltration, and Drug Sensitivity in Colon Cancer.
    He R; Zhang M; He L; Huang J; Man C; Wang X; Lang Y; Fan Y
    Front Med (Lausanne); 2022; 9():845271. PubMed ID: 35479956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of necroptosis-related gene signature and characterization of tumour microenvironment infiltration in non-small-cell lung cancer.
    Dai J; Fu Y
    J Cell Mol Med; 2022 Sep; 26(17):4698-4709. PubMed ID: 35871768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
    Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
    Front Immunol; 2022; 13():968165. PubMed ID: 36389725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.
    Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J
    Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme.
    Li Z; Jin Y; Que T; Zhang XA; Yi G; Zheng H; Yuan X; Wang X; Xu H; Nan J; Chen C; Wu Y; Huang G
    Curr Med Chem; 2024; 31(33):5417-5431. PubMed ID: 37539935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer.
    Pu S; Zhou Y; Xie P; Gao X; Liu Y; Ren Y; He J; Hao N
    Front Immunol; 2022; 13():964118. PubMed ID: 36059470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
    Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
    Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Necroptosis-related Subtypes and Characterization of Tumor Microenvironment Infiltration in Non-small Cell Lung Cancer.
    Deng Y; Lin Y; Zhou B; Jing Q; Zhang W
    Curr Cancer Drug Targets; 2023 Jun; ():. PubMed ID: 37469156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of machine learning-based bulk and single-cell genomics reveals necroptosis-related molecular subtypes and immunological features in autism spectrum disorder.
    Liu L; Fu Q; Ding H; Jiang H; Zhan Z; Lai Y
    Front Immunol; 2023; 14():1139420. PubMed ID: 37168851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
    Xu L; Gao X; Xing J; Guo Z
    Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
    Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
    Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma.
    Fu X; Yang Y; Zhang X
    Front Genet; 2022; 13():919599. PubMed ID: 36134033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.